What if you could detect #autism risk at birth?

By Gita Gupta What if autism could be detected as early as birth, using biomarkers –  rather than at age 2-5 years, using behavioral characteristics? That’s what Dr. Naviaux’s new study aims to find out, using data from the newborn screening program. (You may recall Dr. Naviaux’s groundbreaking work on Suramin in autism – see…

SURAMIN AUTISM TRIAL UPDATE!

By Gita Gupta   Last year, we posted about Dr.Robert Naviaux’s success with the 100 year old drug suramin in a small double-blind, placebo controlled trial of children with autism. All the children who received a single dose of suramin showed improvements in the core symptoms of autism. You can read the parent stories of…

A 100 year old drug improves core symptoms of #autism

By Gita Gupta There are currently no medical treatments approved by the FDA for addressing the disabilities that come with autism. There is plenty of research – over 37,000 peer-reviewed papers touch on various facets of autism. Surprisingly, only a fraction of the research examines how autism affects the body and the brain in medical…